Biotech and pharmaceutical
Through our portfolio of life science tools and solutions we help pharma, biotech, CROs/CDMOs, medical device and consumer healthcare companies provide assurance and high quality data to support their discovery, development and manufacture activities.
In the discovery of new medicines, our cell and molecular standards and genomics reagents and instrumentation help researchers understand the molecular basis of disease and drug action.
LGC’s proprietary oligonucleotide delivery and bioanalytical technologies combined with world-class synthetic chemistry expertise help accelerate the discovery and development of advanced gene and cell-based medicines utilising siRNAs, ASOs, mRNA therapeutics and CRISPR/Cas modalities.
As candidates progress to the clinic, our customers can tap into our cGMP oligonucleotide therapeutic manufacturing suite to provide drug substance for early phase trials.
Pharma and biotech companies developing other drug classes from small chemical entities through to large and complex protein-based biopharmaceuticals benefit from in-depth, specialist bioanalytical capabilities for pharmacokinetics, immunogenicity and biomarkers.
Our Mikromol range of impurity, API and excipient reference materials help our clients control the quality of their manufacture processes. Our global network of GMP analytical laboratories help them optimise and scale up their manufacturing activities and meet the stringent international Chemistry, Manufacture and Controls (CMC), regulations for drug production and release.
We are proud to play a vital role in our customers’ quest to cure diseases and improve quality of lives.
LGC. Science for a safer world.